Shanghai Haoyuan Chemexpress Co. Ltd. A

SHG:688131 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.90 Billion
CN¥13.97 Billion CNY
Market Cap Rank
#6998 Global
#1142 in China
Share Price
CN¥65.85
Change (1 day)
+9.10%
52-Week Range
CN¥34.39 - CN¥88.38
All Time High
CN¥148.50
About

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Shanghai Haoyuan Chemexpress Co. Ltd. A - Asset Resilience Ratio

Latest as of September 2025: 0.96%

Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has an Asset Resilience Ratio of 0.96% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥58.12 Million
Cash + Short-term Investments
Total Assets
CN¥6.07 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Shanghai Haoyuan Chemexpress Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Haoyuan Chemexpress Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥58.12 Million 0.96%
Total Liquid Assets CN¥58.12 Million 0.96%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Haoyuan Chemexpress Co. Ltd. A maintains only 0.96% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Haoyuan Chemexpress Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Haoyuan Chemexpress Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Shanghai Haoyuan Chemexpress Co. Ltd. A (2022–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Haoyuan Chemexpress Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 8.16% CN¥449.15 Million CN¥5.50 Billion +7.68pp
2022-12-31 0.48% CN¥17.23 Million CN¥3.60 Billion --
pp = percentage points